Skip to main content

Advertisement

SpringerLink
Log in

Tracking tumor resistance using 'liquid biopsies'

  • Community Corner
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Murtaza, M. et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108–112 (2013).

    Article  CAS  Google Scholar 

  2. Schwarzenbach, H., Hoon, D.S. & Pantel, K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11, 426–437 (2011).

    Article  CAS  Google Scholar 

  3. Pantel, K., Brakenhoff, R.H. & Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8, 329–340 (2008).

    Article  CAS  Google Scholar 

  4. Heitzer, E. et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res. 73, 2965–2975 (2013).

    Article  CAS  Google Scholar 

  5. Baccelli, I. et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat. Biotechnol. advance online publication, http://dx.doi.org/10.1038/nbt.2576 (2013).

  6. Mandel, P. & Metais, P. Les acides nucleiques du plasma sanguin chez l'homme. C.R. Seances Soc. Biol. Fil. 142, 241–243 (1948).

    CAS  PubMed  Google Scholar 

  7. Diehl, F. et al. Circulating mutant DNA to assess tumor dynamics. Nat. Med. 14, 985–990 (2008).

    Article  CAS  Google Scholar 

  8. Diehl, F. et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc. Natl. Acad. Sci. USA 102, 16368–16373 (2005).

    Article  CAS  Google Scholar 

  9. Dawson, S.J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199–1209 (2013).

    Article  CAS  Google Scholar 

  10. Diaz, L.A. Jr. et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486, 537–540 (2012).

    Article  CAS  Google Scholar 

  11. Leary, R.J. et al. Development of personalized tumor biomarkers using massively parallel sequencing. Sci. Transl. Med. 2, 20ra14 (2010).

    Article  Google Scholar 

  12. Leary, R.J. et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci. Transl. Med. 4, 162ra154 (2012).

    Article  Google Scholar 

  13. Chan, K.C. et al. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin. Chem. 59, 211–224 (2013).

    Article  CAS  Google Scholar 

  14. Forshew, T. et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, 136ra168 (2012).

    Article  Google Scholar 

Download references

Ethics declarations

Competing interests

L.D. is a cofounder of Personal Genome Diagnostics and Inostics, is a member of their scientific advisory boards and owns stock in both companies, which is subject to certain restrictions under Johns Hopkins University policy. The other authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tracking tumor resistance using 'liquid biopsies'. Nat Med 19, 676–677 (2013). https://doi.org/10.1038/nm.3233

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3233

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation